SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-108762
Filing Date
2023-10-12
Accepted
2023-10-12 12:22:20
Documents
16
Period of Report
2023-10-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2328265d1_8k.htm   iXBRL 8-K 33999
2 EXHIBIT 99.1 tm2328265d1_ex99-1.htm EX-99.1 13977
3 EXHIBIT 99.2 tm2328265d1_ex99-2.htm EX-99.2 11427
7 GRAPHIC tm2328265d1_ex99-1img01.jpg GRAPHIC 3528
8 GRAPHIC tm2328265d1_ex99-2img01.jpg GRAPHIC 3528
  Complete submission text file 0001104659-23-108762.txt   257147

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA edsa-20231012.xsd EX-101.SCH 3027
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE edsa-20231012_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE edsa-20231012_pre.xml EX-101.PRE 22367
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2328265d1_8k_htm.xml XML 3282
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37619 | Film No.: 231322175
SIC: 2834 Pharmaceutical Preparations